MBCI.US MabCure Inc

Technology Semiconductors & Semiconductor Equipment USA Stocks
0.0001 USD
Close of Nov 13, 2026
Market cap
USD 78.00
P/E
-
P/B
0.06x
ROE
-321.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2011.

Is MBCI.US undervalued?

Graham number

The Graham number of MabCure Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MabCure Inc fundamental analysis

No fundamental analysis for MabCure Inc yet.

MabCure Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MabCure Inc

MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure, Inc. in January 2008 to reflect its new bus…

Full company profile